COONEY CHARLES L 3
3 · Codiak BioSciences, Inc. · Filed Oct 13, 2020
Insider Transaction Report
Form 3
COONEY CHARLES L
Director
Holdings
Stock Option (Right to Buy)
Exercise: $10.17Exp: 2028-01-31→ Common Stock (11,513 underlying)Stock Option (Right to Buy)
Exercise: $3.29Exp: 2027-07-19→ Common Stock (23,666 underlying)
Footnotes (2)
- [F1]25% of this option vested and became exercisable on July 20, 2018, with the remainder vesting in 12 equal quarterly installments thereafter.
- [F2]25% of this option vested and became exercisable on January 1, 2019, with the remainder vesting in 12 equal quarterly installments thereafter.